How do we bring back generic drug manufacturing to the United States in order to be less reliant on India, China? A National Academies of Science conference brings in some experts to try and answer that, including the chair of CPA Healthcare Committee.
The trend continues. A Chinese couple indicted over biotech trade secret’s lifted from Ohio research hospital.
A Senate hearing today looked back at our early response to the pandemic. A year later, what went right, what went wrong, and how to re-shore pharma now.
It’s time for Elizabeth Warren to re-introduce her pharmaceutical supply chain legislation.
Healthcare panelist and Phlow CEO Eric Edwards on what needs to be done to make more pharmaceutical drugs here. Most of them are coming in from Europe, India and…increasingly…China.
Rosemary Gibson chairs the healthcare committee of the Coalition for a Prosperous America. She is the author of “China Rx: Exposing the Risks of America’s
WASHINGTON—A broad coalition of industry organizations and labor unions, representing a broad spectrum of manufacturers and workers who stepped up to make essential PPE and
By Kenneth Rapoza, CPA Industry Analyst Why are we dependent on China’s pig population for a critical animal source material used in making heparin? Bovine
CPA’s Take: CivicaRX CEO Martin VanTrieste explains why it is essential, and achievable to reshore pharmaceutical production to the US. Two years ago, a group
